CT
BSX icon

Chicago Trust’s Boston Scientific BSX Stock Holding History

Chicago Trust’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Buy
36,064
+3,177
+10% +$173K 0.22% 95
2026
Q1 		$2.06M Buy
32,887
+3,009
+10% +$241K 0.33% 68
2025
Q4 		$2.85M Sell
29,878
-4,307
-13% -$422K 0.45% 48
2025
Q3 		$3.34M Buy
34,185
+1,757
+5% +$182K 0.46% 47
2025
Q2 		$3.48M Buy
32,428
+1,930
+6% +$195K 0.49% 41
2025
Q1 		$3.08M Sell
30,498
-379
-1% -$38.2K 0.55% 41
2024
Q4 		$2.76M Sell
30,877
-339
-1% -$29.8K 0.49% 43
2024
Q3 		$2.62M Buy
31,216
+1,777
+6% +$140K 0.45% 54
2024
Q2 		$2.27M Sell
29,439
-128
-0.4% -$9.37K 0.46% 54
2024
Q1 		$2.03M Sell
29,567
-248
-0.8% -$15.9K 0.42% 67
2023
Q4 		$1.72M Sell
29,815
-598
-2% -$31.9K 0.38% 63
2023
Q3 		$1.61M Buy
30,413
+370
+1% +$19.4K 0.4% 61
2023
Q2 		$1.63M Sell
30,043
-210
-0.7% -$11K 0.39% 66
2023
Q1 		$1.51M Sell
30,253
-9,983
-25% -$470K 0.38% 71
2022
Q4 		$1.86M Buy
40,236
+595
+2% +$25.8K 0.46% 57
2022
Q3 		$1.53M Sell
39,641
-1,145
-3% -$45.9K 0.4% 66
2022
Q2 		$1.52M Sell
40,786
-1,325
-3% -$53.9K 0.38% 71
2022
Q1 		$1.86M Sell
42,111
-2,065
-5% -$89.5K 0.4% 69
2021
Q4 		$1.88M Buy
44,176
+10,511
+31% +$442K 0.37% 75
2021
Q3 		$1.46M Buy
33,665
+398
+1% +$17.6K 0.32% 86
2021
Q2 		$1.42M Buy
33,267
+6,239
+23% +$262K 0.34% 86
2021
Q1 		$1.04M Buy
27,028
+1,275
+5% +$48.3K 0.36% 79
2020
Q4 		$926K Buy
25,753
+778
+3% +$28K 0.32% 90
2020
Q3 		$954K Buy
24,975
+5,561
+29% +$214K 0.4% 77
2020
Q2 		$682K Buy
19,414
+2,948
+18% +$106K 0.3% 94
2020
Q1 		$537K Buy
16,466
+932
+6% +$36.4K 0.27% 96
2019
Q4 		$702K Sell
15,534
-70
-0.4% -$2.93K 0.29% 94
2019
Q3 		$635K Buy
+15,604
New +$661K 0.27% 97

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Chicago Trust's BSX Position: Q2 2026 in Review

Chicago Trust increased its Boston Scientific (BSX) stake by 9.7% in Q2 2026, buying an estimated $173K and bringing the position to 36,064 shares worth $1.54M. The position accounts for 0.22% of the portfolio, ranked #95.

Chicago Trust first reported a position in BSX in Q3 2019 and has held it in 28 quarters since. The position peaked at $3.48M in Q2 2025. 267 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Chicago Trust held 36,064 shares of Boston Scientific worth $1.54M as of Q2 2026.
  • Chicago Trust bought 3,177 Boston Scientific shares in Q2 2026, an estimated $173K.
  • Boston Scientific made up 0.22% of Chicago Trust's portfolio in Q2 2026, its #95 holding.
  • Chicago Trust first reported a position in Boston Scientific in Q3 2019 and has held it in 28 quarters since.
  • Chicago Trust's Boston Scientific position peaked at $3.48M in Q2 2025.
  • 267 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.